Edwin de Graaf - Gilde Healthcare

team
Venture&Growth

All team members
Edwin de Graaf
Managing Partner
healthtech / therapeutics
The Netherlands

Edwin de Graaf

Managing Partner

Edwin de Graaf is founder and managing partner of Gilde Healthcare. Edwin joined Gilde in 1997 following a career of 3 years as a tax consultant with Coopers & Lybrand (now PwC). He is co-responsible for fund management and investment activities of the healthcare venture and growth capital funds and is head of responsible and impact investment.

Edwin de Graaf is a Dutch national and holds a master’s degree in Business and Fiscal Economics from the Erasmus University Rotterdam. He led investments in AM-Pharma (sale minority interest and option agreement with Pfizer), GlycArt (trade sale to Roche), IDEA (license to Alpharma Pharmaceuticals), Omegatech (trade sale to Martek Biosciences, now DSM), Pieris Pharmaceuticals Inc. (Nasdaq: PIRS), Prosonix (trade sale to Circassia), Sanifit Therapeutics, Santaris Pharma (trade sale to Roche), uniQure (Nasdaq: QURE) and WITHINGS and was involved with investments and divestments including adcendo, Ascendis Pharma (Nasdaq: ASND), Definiens (trade sale to AZ/MedImmune), Moximed, ProQr (Nasdaq: PRQR), ProFibrix (trade sale to The Medicines Company) and Sapiens (trade sale to Medtronic). He represented Gilde on the boards of AM Pharma, Ascendis Pharma, Glycart, IDEA, Pieris, Prosonix, Sanifit Therapeutics, Santaris Pharma and uniQure and currently serves on the board WITHINGS and adcendo.

Henry Zubaida

Investment Manager Healthtech
Venture&Growth
Henry Zubaida joined Gilde Healthcare in 2018 and focuses on the Healthtech sector. He has been involved in several investments including Big Health, Withings and Volta Medical. He is a board observer at FIRE1, Withings...

Geoff Pardo

General Partner Healthtech
Venture&Growth
Geoff Pardo joined Gilde Healthcare in 2011 as a Partner working out of the office in Boston/Cambridge, MA and is focusing on Gilde's investments in North America. He led the investments in Ablative Solutions, Inari...

David Nicholson

Operational Partner
David Nicholson is a recognized leader in Pharmaceutical R&D. Most recently he served as Executive Vice President and Chief R&D Officer of Allergan. Previously, he served as Chief Technology Officer and EVP, R&D for a...